NYSEARCA:BOUT Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News $44.33 +0.43 (+0.98%) As of 08/21/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatings About Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BOUT alerts:Sign Up Key Stats Today's Range$43.97▼$44.4850-Day Range$43.90▼$48.9352-Week Range$35.05▼$49.41Volume1,681 shsAverage Volume3,829 shsMarket Capitalization$15.52 millionAssets Under Management$15.37 millionDividend YieldN/ANet Expense Ratio0.85%Aggregate RatingModerate Buy ETF Overview The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator. Read More Innovator IBD Breakout Opportunities ETF ExpensesTypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.80%0.46%0.57%0.51%0.53%Other Expenses0.05%0.36%0.53%0.60%0.54%Total Expense0.85%0.62%0.75%0.75%0.73%Fee Waiver0.00%-0.46%-0.67%-0.77%-0.68%Net Expense0.85%0.52%0.63%0.57%0.60% Receive BOUT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BOUT ETF News HeadlinesSmart beta meets IBD: CapForce rebrands Innovator's IBD funds in rules-based pushApril 29, 2026 | msn.comCapital-FORCE Welcomes IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs to New Rules-Based ETF PlatformApril 29, 2026 | tmcnet.comThese 3 Stocks Could Soar as Sam Altman Announces New Venture After OpenAIElon Musk calls it the most disruptive force in history. Sam Altman is reportedly preparing a new venture after OpenAI, one some say could be 500 times bigger than ChatGPT. Test staff are said to be bound by law to keep details secret, and three lesser-known stocks may be tied to this next chapter in AI. | Stansberry Research (Ad)Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFsApril 17, 2026 | businesswire.comWobbly stock market rally creates this tightrope balancing actApril 8, 2026 | msn.comUS Navy partner in stealth technology targets breakout in murky marketMarch 25, 2026 | msn.comSee More Headlines BOUT ETF - Frequently Asked Questions How have BOUT shares performed this year? Innovator IBD Breakout Opportunities ETF's stock was trading at $36.30 on January 1st, 2026. Since then, BOUT stock has increased by 22.1% and is now trading at $44.33. How do I buy shares of Innovator IBD Breakout Opportunities ETF? Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Innovator IBD Breakout Opportunities ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Carvana (CVNA), Luckin Coffee (LKNCY) and Cloudflare (NET). Fund Details IssuerInnovator Capital Management Fund NameInnovator IBD Breakout Opportunities ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BOUT Inception Date9/13/2018 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIBD Breakout Stocks Index CategoryBroad Equity FocusStrategy Development LevelDeveloped Markets RegionNorth America Number of Holdings27 Fund Statistics Assets Under Management$15.37 million Average Daily Volume$1.70 thousand Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorInnovator Capital Management, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares350,000Beta1.04 Creation Unit50,000 Creation Fee$250.00 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report Top 10 BOUT HoldingsU.S. Bancorp (NYSE:USB)Holding Weight: 7.35%Enliven Therapeutics (NASDAQ:ELVN)Holding Weight: 6.92%Guardant Health (NASDAQ:GH)Holding Weight: 6.83%Urogen Pharma (NASDAQ:URGN)Holding Weight: 6.34%Kiniksa Pharmaceuticals International (NASDAQ:KNSA)Holding Weight: 6.32%The PNC Financial Services Group (NYSE:PNC)Holding Weight: 6.25%Ternium (NYSE:TX)Holding Weight: 6.22%Bicara Therapeutics (NASDAQ:BCAX)Holding Weight: 6.07%Tapestry (NYSE:TPR)Holding Weight: 5.71%Liquidia (NASDAQ:LQDA)Holding Weight: 4.94%Full Holdings DetailsBOUT Sector ExposureBOUT Industry Exposure This page (NYSEARCA:BOUT) was last updated on 8/22/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredYour Free Report (Inside)A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | Sponsored23,281 stocks. Only ONE survived.One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...Monument Traders Alliance | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredThe world's #2 gold miner is running on fumes [it has to buy]Barrick, the world's second-largest gold miner, produced 7.77 million ounces in 2010. This year, output is exp...Golden Portfolio | SponsoredSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD Breakout Opportunities ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
